Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) falls more steeply than broader market: What investors need to know
CRISPR Therapeutics AG (CRSP) closed at $47.69 in the latest trading session, marking a -4.79% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 1.36%. Elsewhere ...
PerturbAI, an AI-native therapeutics company accelerating drug discovery through systems-level understanding of diseases, emerged from stealth today with the public release of the world's largest in ...
A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using ...
The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...
A biotech company says CRISPR could revive extinct animals like the dodo and mammoth — but many scientists remain skeptical.
The Society of the Four Arts is collaborating with the Garden Club of Palm Beach for a lecture featuring botanical genetic ...
CRISPR Therapeutics (CRSP) is back in focus after upsizing its convertible note offering to US$550 million, a key funding ...
A Dallas-based startup says it has produced three “de-extinct” dire wolf pups using gene-editing technology — and the dodo ...
Caribou Biosciences offers the strongest allogeneic CAR-T data to date, with efficacy and safety. Read why I am bullish about ...
For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an ...
The push to revive extinct animals is accelerating, but scientists disagree about whether gene-edited species count as true ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results